NAPRT and leukemia: We demonstrate the possibility of reversing bacterial protection of leukemia cells by optimizing the NAD+-lowering therapy via two alternative strategies: i) simultaneously inhibiting both NAMPT and NAPRT or ii) combining NAMPT inhibition with oral antibiotic therapy aiming at depleting gut microbiota.